Disc Medicine, Inc. (IRON)
Last updated: 2026-10-20 09:14:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Disc Medicine, Inc. (IRON) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $77.14, with a market capitalization of $2.18B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $40.00 to $99.50. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$2.18B | |
$78.18 | |
$99.50 | |
$15.00 | |
$78.93 | |
1.45K | |
625.50K | |
-- | |
$99.50 | |
$40.00 | |
-- | |
-- |
Disc Medicine, Inc. (IRON) Pre-Market Stock Price
Disc Medicine, Inc. (IRON) is trading at $77.14 in pre-market trading as of 2026-10-20 09:13:00, down 2.27% ($1.80) from the previous close of $78.93
Pre-market trading shows how investors are pricing IRON before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Disc Medicine, Inc. (IRON) 7-Day Stock Price Change
Over the past seven days, Disc Medicine, Inc. (IRON) moved from $62.06 to $77.14, representing a gain of 24.29% ($15.08).
The stock traded between $55.00 and $80.22 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 1.73 million shares, up versus the previous seven-day period, indicating higher trading activity.
IRON 52-Week Price Position
Position in Range: 62.4%
IRON is currently trading at $77.14, placing it 62.4% of the way from its 52-week low of $40.00 to its 52-week high of $99.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Disc Medicine, Inc. (IRON)?
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Disc Medicine, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 165 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Disc Medicine, Inc. (IRON) Stock on MEXC
Eligible investors can buy real shares of Disc Medicine, Inc. (IRON) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Disc Medicine, Inc. (IRON) stock price today?
2.Is IRON stock going up or down today?
3.What is IRON pre-market price?
4.What is IRON after-hours price?
5.Is IRON stock trading now?
6.Where does IRON sit relative to its 52-week high and low?
7.What sector is Disc Medicine, Inc. in?
8.What is Disc Medicine, Inc.'s market capitalization and where is it listed?
9.How is IRON valued in terms of P/E ratio and EPS?
10.Does Disc Medicine, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
IRON Stock Calculator
Estimate the value between IRON shares and USD.
IRON Shares to USD
1.00 IRON shares = 77.135 USD
Calculations are estimates based on the latest available price and are for reference only.


